Results 1 - 20 of 3,082 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (2,931)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Still strong reason for enthusiasm for a new stroke-preventing drugLäkartidningen, 2009-11, Vol.106 (45), p.3020-3021 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 19998832Full text available |
| 2 |
Material Type: Article
|
|
New drug in atrial fibrillation--how does it function in regular health care?Läkartidningen, 2009-11, Vol.106 (45), p.3019-3020 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 19998831Full text available |
| 3 |
Material Type: Article
|
|
Treatment of sleep disorders during pregnancy and breast feedingLäkartidningen, 2006-10, Vol.103 (40), p.3012 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 17115673Full text available |
| 4 |
Material Type: Article
|
|
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)Journal of clinical oncology, 2020-06, Vol.38 (18), p.2053-2061 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03296 ;PMID: 32343640Full text available |
| 5 |
Material Type: Article
|
|
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II TrialClinical cancer research, 2021-02, Vol.27 (4), p.1003-1011 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-2571 ;PMID: 33087333Full text available |
| 6 |
Material Type: Article
|
|
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB TrialJournal of clinical oncology, 2020-08, Vol.38 (23), p.2610-2619 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.00775 ;PMID: 32468955Full text available |
| 7 |
Material Type: Article
|
|
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell CarcinomaThe New England journal of medicine, 2021-03, Vol.384 (9), p.829-841 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2026982 ;PMID: 33657295Full text available |
| 8 |
Material Type: Article
|
|
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 TrialCancer discovery, 2018-11, Vol.8 (11), p.1390-14032018 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-18-0264 ;PMID: 30206110Full text available |
| 9 |
Material Type: Article
|
|
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN TrialJournal of clinical oncology, 2017-02, Vol.35 (6), p.591-597 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.7398 ;PMID: 28199818Full text available |
| 10 |
Material Type: Article
|
|
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialThe lancet oncology, 2016-07, Vol.17 (7), p.917-927 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30107-3 ;PMID: 27279544 ;CODEN: LANCAOFull text available |
| 11 |
Material Type: Article
|
|
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del AlleleThe New England journal of medicine, 2019-11, Vol.381 (19), p.1809-1819 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1908639 ;PMID: 31697873Full text available |
| 12 |
Material Type: Article
|
|
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trialThe Lancet (British edition), 2019-11, Vol.394 (10212), p.1940-1948 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32597-8 ;PMID: 31679946Full text available |
| 13 |
Material Type: Article
|
|
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyThe lancet oncology, 2020-06, Vol.21 (6), p.796-807 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30157-1 ;PMID: 32416072Full text available |
| 14 |
Material Type: Article
|
|
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung CancerThe New England journal of medicine, 2020-08, Vol.383 (9), p.813-824 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2005653 ;PMID: 32846060Full text available |
| 15 |
Material Type: Article
|
|
Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion StudyClinical cancer research, 2019-01, Vol.25 (2), p.515-523 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-18-2484 ;PMID: 30348638Full text available |
| 16 |
Material Type: Article
|
|
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid LeukemiaJournal of clinical oncology, 2021-01, Vol.39 (1), p.57-65 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01632 ;PMID: 33119479Full text available |
| 17 |
Material Type: Article
|
|
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trialThe Lancet (British edition), 2021-06, Vol.397 (10292), p.2372-2384 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00666-8 ;PMID: 34090625Full text available |
| 18 |
Material Type: Article
|
|
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trialThe lancet oncology, 2016-04, Vol.17 (4), p.425-439 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00613-0 ;PMID: 26947331 ;CODEN: LANCAOFull text available |
| 19 |
Material Type: Article
|
|
Efficacy of Selpercatinib in RET-Altered Thyroid CancersThe New England journal of medicine, 2020-08, Vol.383 (9), p.825-835 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2005651 ;PMID: 32846061Full text available |
| 20 |
Material Type: Article
|
|
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AMLThe New England journal of medicine, 2018-06, Vol.378 (25), p.2386-2398 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1716984 ;PMID: 29860938Full text available |
Results 1 - 20 of 3,082 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (2,931)
Refine My Results
Creation Date
- Before 1977 (55)
- 1977 To 1987 (103)
- 1988 To 1998 (196)
- 1999 To 2010 (971)
- After 2010 (1,759)
-
More options
New Records
Resource Type
- Articles (3,079)
- Web Resources (2)
- Conference Proceedings (1)
-
More options
Subject
- Pyridines - Administration & Dosage (3,080)
- Science & Technology (2,706)
- Life Sciences & Biomedicine (2,621)
- Humans (2,453)
- Male (1,845)
- Female (1,620)
- Middle Aged (1,142)
- Animals (1,017)
- Adult (991)
- Aged (894)
- Oncology (852)
- Pyridines - Adverse Effects (850)
- Biological And Medical Sciences (820)
- Medical Sciences (765)
- Pharmacology & Pharmacy (689)
- Pyridines - Pharmacology (679)
- Treatment Outcome (660)
- Pyridines - Therapeutic Use (638)
- Dose-Response Relationship, Drug (537)
- Administration, Oral (521)
-
More options
Databases
- MEDLINE (3,080)
- ProQuest Central (1,375)
- Geneva Foundation Free Medical Journals at publisher websites (1,257)
- PubMed Central (807)
- HighWire Press (Free Journals) (583)
- DOAJ Directory of Open Access Journals (532)
- ROAD: Directory of Open Access Scholarly Resources (381)
- Wiley-Blackwell Open Access Collection (241)
- ProQuest One Psychology (165)
- Springer Nature Open Access Journals (161)
- IngentaConnect Free/Open Access Journals (148)
- Nature Free (108)
- Free E- Journals (92)
- Journals@Ovid Open Access Journal Collection Rolling (71)
- Freely Accessible Japanese Titles (52)
- Taylor & Francis Open Access Journals (50)
- PLoS (46)
- Wolters Kluwer Open Health (43)
- Oxford Open (Open Access) (42)
- Sage Journals GOLD Open Access 2024 (37)
-
More options
Language
Journal Title
- Annals Of Oncology (48)
- British Journal Of Cancer (40)
- British Journal Of Clinical Pharmacology (41)
- Cancer Chemotherapy And Pharmacology (54)
- Clinical Cancer Research (101)
- Journal Of Clinical Oncology (67)
- Journal Of Clinical Pharmacology (49)
- Medicine (42)
- Plos One (40)
- Psychopharmacology (35)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||